The Blood Urea Nitrogen (BUN) testing market is experiencing growth due to an increasing prevalence of kidney and liver disorders, alongside a heightened focus on early diagnosis and personalized healthcare. Technological advancements, including AI-enabled and point-of-care testing, are improving the speed and accessibility of tests, enhancing patient convenience, and fostering competition as...